ConductScience.org, home
Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma
API referenceFor AI assistants

Trial · NCT00433537

Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Step 1 - VcR-CVAD InductionSTARTEDVcR-CVAD Induction Followed by Maintenance Rituximab45
Step 1 - VcR-CVAD InductionSTARTEDVcR-CVAD Induction Followed by ASCT22
Step 1 - VcR-CVAD InductionSTARTEDVcR-CVAD Induction Then Off Study10
Step 1 - VcR-CVAD InductionEligible and TreatedVcR-CVAD Induction Followed by Maintenance Rituximab44
Step 1 - VcR-CVAD InductionEligible and TreatedVcR-CVAD Induction Followed by ASCT22
Step 1 - VcR-CVAD InductionEligible and TreatedVcR-CVAD Induction Then Off Study9
Step 1 - VcR-CVAD InductionCOMPLETEDVcR-CVAD Induction Followed by Maintenance Rituximab44
Step 1 - VcR-CVAD InductionCOMPLETEDVcR-CVAD Induction Followed by ASCT22
Step 1 - VcR-CVAD InductionCOMPLETEDVcR-CVAD Induction Then Off Study1
Step 1 - VcR-CVAD InductionNOT COMPLETEDVcR-CVAD Induction Followed by Maintenance Rituximab1
Step 1 - VcR-CVAD InductionNOT COMPLETEDVcR-CVAD Induction Followed by ASCT0
Step 1 - VcR-CVAD InductionNOT COMPLETEDVcR-CVAD Induction Then Off Study9
Step 2 - Maintenance Rituximab or ASCTSTARTEDVcR-CVAD Induction Followed by Maintenance Rituximab45
Step 2 - Maintenance Rituximab or ASCTSTARTEDVcR-CVAD Induction Followed by ASCT22
Step 2 - Maintenance Rituximab or ASCTSTARTEDVcR-CVAD Induction Then Off Study0
Step 2 - Maintenance Rituximab or ASCTEligible and TreatedVcR-CVAD Induction Followed by Maintenance Rituximab44
Step 2 - Maintenance Rituximab or ASCTEligible and TreatedVcR-CVAD Induction Followed by ASCT22
Step 2 - Maintenance Rituximab or ASCTEligible and TreatedVcR-CVAD Induction Then Off Study0
Step 2 - Maintenance Rituximab or ASCTCOMPLETEDVcR-CVAD Induction Followed by Maintenance Rituximab29
Step 2 - Maintenance Rituximab or ASCTCOMPLETEDVcR-CVAD Induction Followed by ASCT22

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00433537/flow

API referenceFor AI assistants